Mereo BioPharma Group (NASDAQ:MREO – Get Free Report)‘s stock had its “buy” rating restated by Needham & Company LLC in a report issued on Wednesday,Benzinga reports. They currently have a $7.00 ...
John Villano; Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer; Sachem Capital Corp Jeffery Walraven; Interim Chief Financial Officer; Sachem Capital Corp ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback